Andrew E. Epstein

Andrew E. Epstein

Auto-generated profile, based on publicly available information

Andrew E. Epstein

University of Pennsylvania

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in JACC
Verified
Journal Article
Open access
AEAndrew E. Epstein
Andrew E. Epstein
WAWilliam T. Abraham
William T. Abraham
NBNicole R. Bianco
Nicole R. Bianco
KKKarl B. Kern
Karl B. Kern
MMMichael Mirro
Michael Mirro
SSSteven J. Szymkiewicz
Steven J. Szymkiewicz
The aim of this study was to describe usage of the wearable cardioverter-defibrillator (WCD) during mandated waiting periods following myocardial infarction (MI) for patients perceived to be at high risk for sudden cardiac arrest (SCA). Current device guidelines and insurance coverage require waiting periods of either 40 days or 3 months before implanting a cardioverter-defibrillator post-myocardial infarction (MI), depending on whether or not acute revascularization was undertaken. We assessed characteristics of and outcomes for patients who had a WCD prescribed in the first 3 months post-MI. The WCD medical order registry was searched for patients who were coded as having had a "recent MI with ejection fraction ≤35%" or given an International Classification of Diseases, Ninth Revision 410.xx diagnostic code (acute MI), and then matched to device-recorded data. Between September 2005 and July 2011, 8,453 unique patients (age 62.7 ± 12.7 years, 73% male) matched study criteria. A total of 133 patients (1.6%) received 309 appropriate shocks. Of these patients, 91% were resuscitated from a ventricular arrhythmia. For shocked patients, the left ventricular ejection fraction (LVEF) was ≤30% in 106, 30% to 35% in 17, >36% in 8, and not reported in 2 patients. Of the 38% of patients not revascularized, 84% had a LVEF ≤30%; of the 62% of patients revascularized, 77% had a LVEF ≤30%. The median time from the index MI to WCD therapy was 16 days. Of the treated patients, 75% received treatment in the first month, and 96% within the first 3 months of use. Shock success resulting in survival was 84% in nonrevascularized and 95% in revascularized patients. During the 40-day and 3-month waiting periods in patients post-MI, the WCD successfully treated SCA in 1.4%, and the risk was highest in the first month of WCD use. The WCD may benefit individual patients selected for high risk of SCA early post-MI.

1 May 2016 in The American Journal of Medicine
Verified
Journal Article
Closed access
AEAndrew E. Epstein
Andrew E. Epstein
BOBrian Olshansky
Brian Olshansky
GNGerald V. Naccarelli
Gerald V. Naccarelli
JKJohn I. Kennedy
John I. Kennedy
EMElizabeth J. Murphy
Elizabeth J. Murphy
NGNora Goldschlager
Nora Goldschlager

12 November 2022 in European Heart Journal Open
Verified
Journal Article
Open access
PDF file
MCMafalda Carrington
Mafalda Carrington
RPRui Providencia
Rui Providencia
CCC. Anwar A. Chahal
C. Anwar A. Chahal
Fabrizio RicciFabrizio Ricci
Fabrizio Ricci
AEAndrew E Epstein
Andrew E Epstein
MKMohammed Y Khanji
Mohammed Y Khanji
Technological advances have made diagnosis of heart rhythm disturbances much easier, with a wide variety of options, including single-lead portable devices, smartphones/watches to sophisticated implantable cardiac monitors, allowing accurate data to be collected over different time periods depending on symptoms frequency. This review provides an overview of the novel and existing heart rhythm testing options, including a description of the supporting evidence for their use. A description of each of the tests is provided, along with discussion of their advantages and limitations. This is intended to help clinicians towards choosing the most appropriate test, thus improving diagnostic yield management of patients with suspected arrhythmias.

1 October 2016 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
BDBenjamin A. D’sOuza
Benjamin A. D’sOuza
AEAndrew E. Epstein
Andrew E. Epstein
FGFermin C. Garcia
Fermin C. Garcia
YKYuli Y. Kim
Yuli Y. Kim
SASharad C. Agarwal
Sharad C. Agarwal
MSMaully Shah
Maully Shah

17 December 2001 in JACC
Verified
Journal Article
Closed access
PDF file
GWGregory P Walcott
Gregory P Walcott
GKG.Neal Kay
G.Neal Kay
VPVance J Plumb
Vance J Plumb
WSWilliam M Smith
William M Smith
JRJack M Rogers
Jack M Rogers
RIRaymond E Ideker
Raymond E Ideker

27 January 2016 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
NVNiraj Varma
Niraj Varma
AEAndrew E. Epstein
Andrew E. Epstein
RSRobert Schweikert
Robert Schweikert
JMJustin Michalski
Justin Michalski
CLCharles J. Love
Charles J. Love
TITRUST Investigators
TRUST Investigators